Astorg Completes Acquisition of Thermo Fisher Microbiology Business
Astorg has completed its acquisition of Thermo Fisher’s global microbiology business, establishing an independent diagnostics company Dirk Bontridder has been named CEO.
Category: Company News
Company News
Latest
Company News
Latest
Roche and Ivy Tech Partner to Address Medical Laboratory Workforce Shortages in Indiana
Roche Diagnostics North America and Ivy Tech Community College have launched a multi-phase initiative, including scholarships and an awareness campaign, to address clinical lab workforce shortages in Indiana.
Company News
Latest
Alamar Gains Rights to Develop Clinical Alzheimer’s Blood Tests Using ALZpath Antibody
ALZpath and Alamar Biosciences have expanded their partnership, granting Alamar commercial rights to use ALZpath’s pTau217 antibody in clinical blood tests for Alzheimer’s disease.
Anthem to Cover Quanterix’s LucentAD Complete Alzheimer’s Blood Test
The insurer will provide coverage for the multi-analyte test starting July 2026, following new data showing parity with mass spectrometry.
Read More
Anthem Establishes Coverage of C2N Diagnostics’ Blood Test for Alzheimer’s Disease Evaluation
Anthem Blue Cross and Blue Shield will cover C2N Diagnostics’ PrecivityAD2 blood test for Alzheimer’s disease evaluation starting Oct 1, 2026, expanding access to the diagnostic tool for adults with cognitive decline.
Read More
Labcorp Expands Access to Non-Invasive MASH Blood Test Through Online Platform
The NASHnext assay, powered by GENFIT’s NIS4 technology, is designed to identify patients with at-risk MASH through a blood draw ordered via the Labcorp OnDemand platform.
Read More
Freenome Reports Clinical Validation Results for Updated Colorectal Cancer Blood Test
Freenome’s updated SimpleScreen CRC blood test met all primary and secondary endpoints in clinical validation, with improved sensitivity for precancerous lesions and colorectal cancer.
Read More
Roche to Share New Data on Elecsys Alzheimer’s Blood Tests at AAIC
Presentations will evaluate the performance of the company’s pTau217 and pTau181 assays while also highlighting phase 3 clinical research for the investigational therapy trontinemab for Alzheimer’s disease.
Read More
ADLM Appoints New Chief Scientific Officer
The new officer, bringing more than 15 years of experience in diagnostics and data science to the association, will lead scientific strategy and partnerships.
Read More
Lilly to Present Data Comparing P-Tau217 Blood Tests With Amyloid PET at AAIC
Presentations at the upcoming Alzheimer’s Association International Conference include data comparing P-tau217 blood biomarker tests with amyloid PET, along with new long-term safety findings for donanemab.
Read More
Stanford Blood Center Launches Infectious Disease Testing for Organ and Tissue Donors
The new service supports transplantation medicine for 13 million people across Northern California and Northern Nevada.
Read More
Quest Diagnostics Integrates Oncology Tests into Electronic Health Record Platform
A pilot program with American Oncology Network allows clinicians to order molecular tests and receive results within their existing workflow.
Read More
Siemens Healthineers Launches New Hematology Analyzer for US Laboratories
The Atellica HEMA 580 is designed for mid- to high-volume labs to automate testing workflows and reduce preanalytical variability.
Read More
Caris Life Sciences Launches New Blood Test for Early Cancer Detection
The test utilizes genomic sequencing and AI to identify biological signals associated with early-stage disease.
Read More
Eurobio Scientific Finalizes Acquisition of CareDx Lab Product Division
The transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read More
UnitedHealth Group Covers Shield Blood Test for Colorectal Cancer Screening
The Shield test is now available to eligible members aged 45 and older, expanding access to screening options for colorectal cancer.
Read More
ADLM Names New Leadership for 2026
Christina Lockwood, PhD, will serve as president-elect starting in August 2026, followed by a term as president in 2027.
Read More
Pictor Holdings Secures $7.5 Million to Expand Protein Analysis Platform
The funding will support manufacturing and commercial partnerships for a system that analyzes multiple protein targets in less than two hours.
Read More